Literature DB >> 11720153

Review of treatment of pterygium in Queensland: 10 years after a primary survey.

R Troutbeck1, L Hirst.   

Abstract

PURPOSE: To assess the practices in pterygium removal as a follow-up study to a similar project 10 years ago, in order to compare the current trends with those noted a decade ago.
METHODS: A survey was sent to all practising ophthalmologists in Queensland (100).
RESULTS: Eighty-seven of the 100 ophthalmologists undertook pterygium surgery with no change in indications for removal, grading or anaesthesia compared to 10 years ago. Nearly half of the ophthalmologists varied their surgical technique from eight commonly used methods according to the individual patient. More than half the respondents used a swinging conjunctival flap and 29% used simple excision leaving the area bare for primary pterygia, although nearly one-quarter of the ophthalmologists added adjunctive therapies such as beta irradiat on or mitomycin. For recurrent pterygia, one-third of ophthalmologists preferred adjunctve therapies, and 57% used an autoconjunctival transplant.
CONCLUSION: There has been no consistent trend in surgical removal of pterygia with a significant number of primary pterygia still removed using bare scleral closure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720153     DOI: 10.1046/j.1442-9071.2001.00435.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  3 in total

1.  Efficacy of Limbal-conjunctival Autograft Surgery with Stem Cells in Pterygium Treatment.

Authors:  Walid M Abdalla
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

2.  Awareness of treatment: A source of bias in subjective grading of ocular complications.

Authors:  Genis Cardona; Noelia Esterich
Journal:  PLoS One       Date:  2019-12-26       Impact factor: 3.240

3.  A Survey of Surgical Techniques in Pterygium, Thailand 2016.

Authors:  Saovapak Phathanthurarux; Patchima Chantaren
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019 Nov-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.